Advertisement

Topics

InflaRx N.V. Company Profile

00:51 EDT 20th August 2018 | BioPortfolio

InflaRx (Nasdaq:IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. Complement C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. InflaRx was founded in 2007 and has offices in Jena and Munich, Germany. InflaRx is listed on the NASDAQ Global Select Market in the United States under the trading symbol "IFRX."


News Articles [17 Associated News Articles listed on BioPortfolio]

In The Spotlight: Inflarx

Shares of Inflarx NV (IFRX) are up more than 50% year-to-date while the iShares NASDAQ Biotechnology Index (ETF) has gained only 2% during the same period.

InflaRx gets IND approval from US FDA to start phase II trial of IFX─1 in ANCA associated vasculitis

InflaRx N.V., a biopharmaceutical company developing innovative therapeutics to treat life─threatening inflammatory diseases by targeting the complement system, a key component of the innate immune ...

InflaRx's IND for ANCA-associated vasculitis drug approved by FDA

The investigative new drug application for InflaRx's drug candidate IFX-1 was approved by the FDA, allowing the company to la -More- 

Active-Investors: Blog Exposure - InflaRx Enrolled First Patient in Phase-IIb Trial of Lead Candidate IFX-1 in Hidradenitis Suppurativa

Stock Monitor: bluebird bio Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 12, 2018 / Active-Investors.com has just released a free research report on InflaRx N.V. (NASDAQ: IFRX). If you w...

InflaRx: Buy The Dip

InflaRx raises $51M follow-on

The Investment Case For InflaRx

Reader Inquiry: Is InflaRx A Buy On The Dip?

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

InflaRx N.V.

InflaRx (Nasdaq:IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and spec...

InflaRx GmbH

InflaRx is a clinical-stage biopharmaceutical company focusing on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibito...

InflaRx

About: Affentranger Associates SA

More Information about "InflaRx N.V." on BioPortfolio

We have published hundreds of InflaRx N.V. news stories on BioPortfolio along with dozens of InflaRx N.V. Clinical Trials and PubMed Articles about InflaRx N.V. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of InflaRx N.V. Companies in our database. You can also find out about relevant InflaRx N.V. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...


Corporate Database Quicklinks



Searches Linking to this Company Record